Angiotensin II type 2 receptor promotes apoptosis and inhibits angiogenesis in bladder cancer-Reference-Cited by-同舟云学术

Angiotensin II type 2 receptor promotes apoptosis and inhibits angiogenesis in bladder cancer

Published:2017-06-09 Issue:1 Volume:36 Page:
ISSN:1756-9966
Container-title:Journal of Experimental & Clinical Cancer Research
language:en
Short-container-title:J Exp Clin Cancer Res

Author:

Pei Nana,Mao Yingying,Wan Pengfei,Chen Xinglu,Li Andrew,Chen Huiying,Li Jinlong,Wan Renqiang,Zhang Yanling,Du Hongyan,Chen Baihong,Jiang Guangyu,Xia Minghan,Sumners Colin,Hu Guixue,Gu Dongsheng,Li Hongwei

Funder

National Natural Science Foundation of China Grants

Guangdong Province Science and Technology Project

the Fundamental Research Funds for the Central Universities

awards from the Chinese government.

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://link.springer.com/content/pdf/10.1186/s13046-017-0542-0.pdf

Reference47 articles.

1. Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87–108.

2. Cheng L, Davison DD, Adams J, Lopez-Beltran A, Wang L, Montironi R, Zhang S. Biomarkers in bladder cancer: translational and clinical implications. Crit Rev Oncol Hematol. 2014;89:73–111.

3. Gan C, Mostafid H, Khan MS, Lewis DJ. BCG immunotherapy for bladder cancer-the effects of substrain differences. Nat Rev Urol. 2013;10:580–8.

4. Killion JJ, Fidler IJ. The biology of tumor metastasis. Semin Oncol. 1989;16:106–15.

5. Fidler IJ, Hart RI. Biological diversity in metastatic neoplasms: origins and implications. Science. 1982;217:998–1003.

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Agonists of galanin subtype 2 receptor may prevent pancreatic cancer and agonists of angiotensin II type 2 receptor may prevent colorectal cancer;European Journal of Pharmacology;2024-09

2. Advanced progress of the relationship between renin–angiotensin–aldosterone system inhibitors and cancers;Journal of Hypertension;2024-08-08

3. Use of angiotensin‑converting enzyme inhibitors in gynecological cancers: Pathways and mechanisms involved (Review);World Academy of Sciences Journal;2024-07-08

4. Genetic variants in the renin-angiotensin-aldosterone system: Impact on cancer risk, prognosis, and therapeutic directions;Vitamins and Hormones;2024

5. Evolving views on the first two ligands of the angiotensin II type 2 receptor. From putative antagonists to potential agonists?;European Journal of Pharmacology;2023-12